Dr. Michael D. Fleming currently serves as the Consumer Representative on the Dental Products Panel at the Center for Devices and Radiological Health of the FDA and has served on two separate hearings on the safety of dental amalgam in 2006 and 2010. In this video he expresses his views on the need for informed consent in regards to dental mercury amalgam fillings.
The Food and Drug Administration FDA has aggressively removed dietary supplement Oxidative Stress Relief (OSR) from the market. Among other things, OSR helped to raise Glutathione levels, which is the body's natural detoxification system.
The International Academy of Oral Medicine and Toxicology presents the backstory and lead up to the 2010 FDA hearing on amalgam safety.
FDA’s August 4, 2009, Final Rule classifying dental amalgam in Class II and concomitant failure to prepare an Environmental Impact Statement, or at least, and Environmental Assessment under the National Environmental Protection Act (“NEPA.”)
In 2008 a group of widely published mercury researchers took two dozen new studies indicating harm from mercury vapor emitted from dental amalgam fillings to FDA's associate commissioner of science, Norris Alderson. While Alderson told them he agreed with them, he stated he couldn't do anything about it unless they (the researchers) got the American Dental Association to agree with them.
Mercuryexposure.info was created and is maintained by consumers injured from exposure to mercury vapor and particles released by their dental amalgam fillings during placement, polishing, removal and day to day use. We are dedicated to providing accurate, up to date information on the many facets of dental mercury amalgam fillings.